Maria Zambon

Last updated

Maria Caterina Zambon [1] FMedSci FRCPath, is a British virologist, director of reference microbiology for Public Health England and a professor. Her main research areas include influenza vaccination and influenza hemagglutination inhibition. [2]

Contents

Life and work

In 1984, Zambon earned a PhD from the University of London (Imperial College) with a thesis titled "Inhibition of influenza virus replication by 1-aminoadamantane". [1] This work on "the mechanism of action of amantadine ... led directly to the identification of a novel class of viral proteins, viral ion channels (M2 protein)", [3] research in which she participated further in the following years. [4]

She leads her own research group devoted to respiratory virus diagnosis, surveillance and integrated clinical research programmes, with particular emphasis on influenza and other respiratory viruses.  She also coordinates several multinational European Union projects devoted to influenza vaccines and antivirals.  Primarily, her research concentrates on the diagnoses of viral infections in humans, with particular attention on "RNA viruses, the pathogenicity of influenza and development of new vaccines for respiratory viruses, particularly influenza".  In addition, she has been instrumental in the development of vaccines for avian influenza and took part of a successful UK consortium that conducted clinical trials of the H5, H7 and H9 vaccines. [3]

Zambon is one of the 23 attendees of the Scientific Advisory Group for Emergencies (Sage). [5] She was a member of the Coronaviridae Study Group of the International Committee on Taxonomy of Viruses and contributed to the scientific description of MERS-CoV's taxonomy. [6]

Maria Zambon and her colleague Joanna Ellis contributed to the development of the first real-time RT-PCR test for SARS-CoV-2, which was led by Christian Drosten. [7] [8]

Honors

In 2011, she was elected a fellow of the Academy of Medical Sciences. [9] She is a fellow of the Royal College of Pathologists. [10]

Related Research Articles

<i>Orthomyxoviridae</i> Family of RNA viruses including the influenza viruses

Orthomyxoviridae is a family of negative-sense RNA viruses. It includes seven genera: Alphainfluenzavirus, Betainfluenzavirus, Gammainfluenzavirus, Deltainfluenzavirus, Isavirus, Thogotovirus, and Quaranjavirus. The first four genera contain viruses that cause influenza in birds and mammals, including humans. Isaviruses infect salmon; the thogotoviruses are arboviruses, infecting vertebrates and invertebrates. The Quaranjaviruses are also arboviruses, infecting vertebrates (birds) and invertebrates (arthropods).

<span class="mw-page-title-main">Rimantadine</span> Drug used to treat influenzavirus A infection

Rimantadine is an orally administered antiviral drug used to treat, and in rare cases prevent, influenzavirus A infection. When taken within one to two days of developing symptoms, rimantadine can shorten the duration and moderate the severity of influenza. Rimantadine can mitigate symptoms, including fever. Both rimantadine and the similar drug amantadine are derivates of adamantane. Rimantadine is found to be more effective than amantadine because when used the patient displays fewer symptoms. Rimantadine was approved by the Food and Drug Administration (FDA) in 1994.

<span class="mw-page-title-main">Amantadine</span> Medication used to treat dyskinesia

Amantadine, sold under the brand name Gocovri among others, is a medication used to treat dyskinesia associated with parkinsonism and influenza caused by type A influenzavirus, though its use for the latter is no longer recommended because of widespread drug resistance. It acts as a nicotinic antagonist, dopamine agonist, and noncompetitive NMDA antagonist. The antiviral mechanism of action is antagonism of the influenzavirus A M2 proton channel, which prevents endosomal escape.

Viral pneumonia is a pneumonia caused by a virus. Pneumonia is an infection that causes inflammation in one or both of the lungs. The pulmonary alveoli fill with fluid or pus making it difficult to breathe. Pneumonia can be caused by bacteria, viruses, fungi or parasites. Viruses are the most common cause of pneumonia in children, while in adults bacteria are a more common cause.

<span class="mw-page-title-main">Influenza</span> Infectious disease, often just "the flu"

Influenza, commonly known as "the flu" or just "flu", is an infectious disease caused by influenza viruses. Symptoms range from mild to severe and often include fever, runny nose, sore throat, muscle pain, headache, coughing, and fatigue. These symptoms begin from one to four days after exposure to the virus and last for about 2–8 days. Diarrhea and vomiting can occur, particularly in children. Influenza may progress to pneumonia, which can be caused by the virus or by a subsequent bacterial infection. Other complications of infection include acute respiratory distress syndrome, meningitis, encephalitis, and worsening of pre-existing health problems such as asthma and cardiovascular disease.

<span class="mw-page-title-main">MERS</span> Viral respiratory infection

Middle East respiratory syndrome (MERS) is a viral respiratory infection caused by Middle East respiratory syndrome–related coronavirus (MERS-CoV). Symptoms may range from none, to mild, to severe depending on age and risk level. Typical symptoms include fever, cough, diarrhea, and shortness of breath. The disease is typically more severe in those with other health problems.

Peter John Morland Openshaw, is a British clinician and scientist specialising in lung immunology, particularly defence against viral infections. He trained in lung diseases and undertook a PhD in immunology before establishing a laboratory at St Mary's Hospital Medical School. He created the academic department of Respiratory Medicine and the Centre for Respiratory Infection at Imperial College and was elected President of the British Society for Immunology in 2014.

<span class="mw-page-title-main">Wendy Barclay</span> British virologist

Wendy Sue Fox is a British virologist. She is currently head of Department of Infectious Disease and chair in Influenza Virology at Imperial College London. She leads a team of scientists studying the influenza virus and its physiology and morphology to discover novel vaccines. In particular, they are trying to understand more about influenza virus mutations, and how they can allow scientists to create new vaccines against possible flu pandemics.

<span class="mw-page-title-main">Coalition for Epidemic Preparedness Innovations</span> Public-private organization for vaccine development

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

Charles Bangham holds the Chair in Immunology at Imperial College London.

<span class="mw-page-title-main">Sarah Gilbert</span> English vaccinologist (born 1962)

Dame Sarah Catherine Gilbert FRS is an English vaccinologist who is a Professor of Vaccinology at the University of Oxford and co-founder of Vaccitech. She specialises in the development of vaccines against influenza and emerging viral pathogens. She led the development and testing of the universal flu vaccine, which underwent clinical trials in 2011.

<span class="mw-page-title-main">Christian Drosten</span> German virologist researching emergent viruses

Christian Heinrich Maria Drosten is a German virologist whose research focus is on novel viruses (emergent viruses). During the COVID-19 pandemic, Drosten came to national prominence as an expert on the implications and actions required to combat the illness in Germany.

Maria DeJoseph Van Kerkhove is an American infectious disease epidemiologist. With a background in high-threat pathogens, Van Kerkhove specializes in emerging and re-emerging infectious diseases and is based in the Health Emergencies Program at the World Health Organization (WHO). She is the technical lead of COVID-19 response and the head of emerging diseases and zoonosis unit at WHO.

The Scientific Advisory Group for Emergencies (SAGE) is a British Government body that advises central government in emergencies. It is usually chaired by the United Kingdom's Chief Scientific Adviser. Specialists from academia and industry, along with experts from within government, make up the participation, which will vary depending on the emergency. SAGE gained public prominence for its role in the 2020 COVID-19 pandemic in the United Kingdom.

<span class="mw-page-title-main">Jonathan Van-Tam</span> British public health physician

Sir Jonathan Stafford Nguyen Van-Tam is a British healthcare professional specialising in influenza, including its epidemiology, transmission, vaccinology, antiviral drugs and pandemic preparedness.

<span class="mw-page-title-main">Kizzmekia Corbett</span> American immunologist

Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.

Allison Joan McGeer is a Canadian infectious disease specialist in the Sinai Health System, and a professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She also appointed at the Dalla Lana School of Public Health and a Senior Clinician Scientist at the Lunenfeld-Tanenbaum Research Institute, and is a partner of the National Collaborating Centre for Infectious Diseases. McGeer has led investigations into the severe acute respiratory syndrome outbreak in Toronto and worked alongside Donald Low. During the COVID-19 pandemic, McGeer has studied how SARS-CoV-2 survives in the air and has served on several provincial committees advising aspects of the Government of Ontario's pandemic response.

Eleni Nastouli is a Greek clinical virologist who works at University College London Hospitals NHS Foundation Trust (UCLH) and Great Ormond Street Hospital. At UCLH, Nastouli leads the Advanced Pathogen Diagnostics Unit, where she develops technologies for genome sequencing as well as studying how viruses are transmitted around hospitals. During the COVID-19 pandemic Nastouli led an investigation into infection rates amongst healthcare workers.

Sir William John Edmunds is a British epidemiologist, and a professor in the Faculty of Epidemiology and Population Health at the London School of Hygiene & Tropical Medicine.

Vaccine-associated enhanced respiratory disease (VAERD), or simply enhanced respiratory disease (ERD), is an adverse event where an exacerbated course of respiratory disease occurs with higher incidence in the vaccinated population than in the control group. It is a barrier against vaccine development that can lead to its failure.

References

  1. 1 2 Her thesis on 1 -aminoadamantane (also named amantadine) can be downloaded by using a link associated to the thesis' title in her Google Scholar profile.
  2. ↑ "Zambon, Maria C." SCOPUS. Retrieved 14 June 2021. h-index:75
  3. 1 2 "Maria Zambon, Public Health England, UK". ISIRV. Retrieved 25 April 2020.
  4. ↑ "Specific structural alteration of the influenza haemagglutinin by amantadine". The EMBO journal. Retrieved 14 June 2021.
  5. ↑ Sample, Ian (24 April 2020). "Who's who on secret scientific group advising UK government?". The Guardian. Retrieved 24 April 2020.
  6. ↑ "Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group". ASM, Journal of Virology. Retrieved 14 June 2021.
  7. ↑ "Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR". Eurosurveillance. Retrieved 14 June 2021.
  8. ↑ "Diagnostic detection of 2019-nCoV by real-time RT-PCR" (PDF). WHO. 17 January 2020. Retrieved 14 June 2021.
  9. ↑ "Professor Maria Zambon FMedSci". Academy of Medical Sciences. Retrieved 25 April 2020.
  10. ↑ "National Infection Service - latest information regarding 2019-nCoV coronavirus". Royal College of Pathologists. 7 February 2020. Retrieved 25 April 2020. Professor Maria Zambon BSc BMBCh PhD FRCPath FMedSci
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.